Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocase Brasil is a prominent healthcare company in Brazil specializing in the medical cannabis sector. The company focuses on the import, distribution, and commercialization of high-quality cannabinoid-based products for various clinical conditions. Their portfolio includes a range of formulations such as full-spectrum oils and isolated CBD, catering to patients with epilepsy, chronic pain, and neurodegenerative disorders. A core pillar of their business is the Biocase Academy, which provides specialized medical education to healthcare professionals to bridge the knowledge gap in cannabinoid therapy. Biocase also offers comprehensive support to patients, assisting them with the legal and regulatory processes required by ANVISA for importing controlled medications. By partnering with international manufacturers, the company ensures a steady supply of pharmaceutical-grade cannabis to the Brazilian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocase Brasil.